Provided by Tiger Trade Technology Pte. Ltd.

Cardiff Oncology, Inc.

0.8801
-0.0286-3.15%
Post-market: 0.90700.0269+3.05%19:44 EDT
Volume:653.49K
Turnover:592.10K
Market Cap:68.36M
PE:-1.49
High:0.9289
Open:0.9266
Low:0.8800
Close:0.9087
52wk High:3.31
52wk Low:0.7566
Shares:77.67M
Float Shares:75.24M
Volume Ratio:1.17
T/O Rate:0.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5914
EPS(LYR):-0.6863
ROE:-94.08%
ROA:-46.73%
PB:2.58
PE(LYR):-1.28

Loading ...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Cardiff Oncology (CRDF), ACADIA Pharmaceuticals (ACAD) and Immunic (IMUX)

TIPRANKS
·
May 22

Cardiff Oncology updates Phase 2 onvansertib data in first-line RAS-mutated mCRC trial

Reuters
·
May 22

Cardiff Oncology Sues Nerviano As Analyst Backs Onvansertib Defense

Benzinga
·
May 21

Cardiff Oncology Inc - Seeks Injunctive Relief and Declaratory Judgment in Lawsuit Against Nms - SEC Filing

THOMSON REUTERS
·
May 20

Cardiff Oncology Inc - Files Lawsuit Against Nerviano Medical Sciences Over Breach of Onvansertib License Agreement - SEC Filing

THOMSON REUTERS
·
May 20

Cardiff Oncology sues Nerviano Medical Sciences over onvansertib license dispute

Reuters
·
May 20

Analysts Offer Insights on Healthcare Companies: Agilon Health (AGL) and Cardiff Oncology (CRDF)

TIPRANKS
·
May 19

Cardiff Oncology (CRDF) Gets a Buy from H.C. Wainwright

TIPRANKS
·
May 15

Cardiff Oncology Q1 Basic EPS USD -0.18

THOMSON REUTERS
·
May 15

Corrected-Cardiff Oncology Q1 Royalty Revenue USD 41 Thousand (Corrects Amount)

THOMSON REUTERS
·
May 15

Cardiff Oncology sees cash, equivalents funding operations into 1Q27

TIPRANKS
·
May 15

Cardiff Oncology Q1 EPS $(0.18) Misses $(0.15) Estimate, Sales $41.000K Miss $85.000K Estimate

Benzinga Earnings
·
May 15

Cardiff Oncology Reports First Quarter 2026 Results and Provides Business Update

THOMSON REUTERS
·
May 15

Cardiff Oncology Q1 FY26 net loss narrows to $12.3 million; revenue drops to $41,000

Reuters
·
May 15

Cardiff Oncology Inc expected to post a loss of 13 cents a share - Earnings Preview

Reuters
·
May 04

Cardiff Oncology COO Ajay Aggarwal files initial beneficial ownership statement

Reuters
·
Apr 29

Cardiff Oncology grants COO inducement options for 400,000 shares at $1.72 each

Reuters
·
Apr 29

Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Apr 29

Cardiff Oncology to host KOL webinar on onvansertib single-agent CMML data

Reuters
·
Apr 27

Cardiff Oncology announces annual shareholder meeting

Reuters
·
Apr 24